Finance
The acquisition includes all of NeuroReality's assets, including its flagship rehabilitation product, Koji's Quest.
The company reported a 77% YOY increase in revenue in Q3 2024 and plans to release a generic version of Novo Nordisk's GLP-1 drug on its platform in 2025.
The acquisition includes Jack's Canadian clinical assets, the authority to operate 16 medical clinics across 13 Canadian cities and the rights to operate clinics in Walmart stores in Canada.
Last week, the wearables company announced it opened an investigation into apparent manipulation in trading its common shares following a 1-for-15 reverse stock split.
The acquisition of data company Sparta Science will allow Oura to expand its data analytics capabilities and its B2B offerings.
The investigation follows shareholder approval of a 1-for-15 reverse stock that took effect earlier this week.
The funding includes $4.5 billion for the firm's core VC funds, $1.5 billion for its Creation strategy and $2 billion for separately managed accounts.
Also, Orion Health is coming up with a combined clinical solution with Te Whatu Ora.
The company will be subject to a 12-month follow-up review period to assure that it does not fall below NYSE standards.
The acquisition allows Resilience Lab to integrate Options MD's medication management and psychotherapy offerings for individuals with severe mental illness.